Gene · 7114
Papers2,131
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,131
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tβ4-Engineered ADSC Extracellular Vesicles Rescue Cell Senescence Through Separable Microneedle Patches for Diabetic Wound Healing. | Adv Sci (Weinh) | 2025 | 40279568 | PubTator, text mining | PubMed |
| Protein to biomaterials: Unraveling the antiviral and proangiogenic activities of Ac-Tβ1-17 peptide, a thymosin β4 metabolite, and its implications in peptide-scaffold preparation. | Bioact Mater | 2025 | 40177110 | PubTator, text mining | PubMed |
| Proteomic biomarkers in psoriatic arthritis. | Clin Chim Acta | 2025 | 40096904 | PubTator, text mining | PubMed |
| Tβ4-exosome-loaded hemostatic and antibacterial hydrogel to improve vascular regeneration and modulate macrophage polarization for diabetic wound treatment. | Mater Today Bio | 2025 | 40070869 | PubTator, text mining | PubMed |
| Retraction: The role of thymosin beta 4 on odontogenic differentiation in human dental pulp cells. | PLoS One | 2025 | 40029897 | PubTator, text mining | PubMed |
| Nanofibrous Scaffolds' Ability to Induce Mesenchymal Stem Cell Differentiation for Soft Tissue Regenerative Applications. | Pharmaceuticals (Basel) | 2025 | 40006052 | PubTator, text mining | PubMed |
| Exploring the Relationship Between Thymosin β4 Protein and First Myocardial Infarction on the Basis of Proteomics. | J Am Heart Assoc | 2025 | 39950438 | PubTator, text mining | PubMed |
| Epimedin C promotes mitochondrial transfer and delays thymus atrophy in 4-VCD induced mimetic-menopausal mice. | Phytomedicine | 2025 | 39919331 | PubTator, text mining | PubMed |
| Identification of glutamine as a potential therapeutic target in dry eye disease. | Signal Transduct Target Ther | 2025 | 39837870 | PubTator, text mining | PubMed |
| A comprehensive analysis to reveal the underlying molecular mechanisms of natural killer cell in thyroid carcinoma based on single-cell RNA sequencing data. | Discov Oncol | 2025 | 39808350 | PubTator, text mining | PubMed |
| Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway. | Free Radic Biol Med | 2025 | 39761767 | PubTator, text mining | PubMed |
| Extracellular vesicle therapeutics for cardiac repair. | J Mol Cell Cardiol | 2025 | 39603560 | PubTator, text mining | PubMed |
| Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway. | J Pharm Pharmacol | 2025 | 39579076 | PubTator, text mining | PubMed |
| Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression. | Front Immunol | 2024 | 39742274 | PubTator, text mining | PubMed |
| TMSB4X is a regulator of inflammation-associated ferroptosis, and promotes the proliferation, migration and invasion of hepatocellular carcinoma cells. | Discov Oncol | 2024 | 39556271 | PubTator, text mining | PubMed |
| Spatial transcriptomics analysis identifies therapeutic targets in diffuse high-grade gliomas. | Front Mol Neurosci | 2024 | 39530009 | PubTator, text mining | PubMed |
| Programmable biomaterials for bone regeneration. | Mater Today Bio | 2024 | 39469314 | PubTator, text mining | PubMed |
| Beneficial effects of a combined lifestyle intervention for older people in a long-term-care facility on redox balance and endothelial function. | Heliyon | 2024 | 39220897 | PubTator, text mining | PubMed |
| Thymosin β4 and β10 Expression in Human Organs during Development: A Review. | Cells | 2024 | 38994967 | PubTator, text mining | PubMed |
| ScHGSC-IGDC: Identifying genes with differential correlations of high-grade serous ovarian cancer based on single-cell RNA sequencing analysis. | Heliyon | 2024 | 38975079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7114/papers?page=4